Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 54

Sort by

Sort Order Select

Journal Articles

Expression Profiling of mRNA By Next Generation Sequencing and the Development of Algorithm for Predicting Response in Acute Myeloid Leukemia

Maher Albitar, MD, Marina Y Konopleva, MD PhD, Hong Zhang, PhD, Ivan De Dios, BS, Wanlong Ma, Spiraggelos Antzoulatos, Steven M. Kornblau, MD, Antonio Cavazos, Sanam Loghavi, MD, Koichi Takahashi, MD, Hagop M. Kantarjian, MD, Courtney D. DiNardo, MDMSc

Blood (2019) 134 (Supplement_1): 1314.

https://doi.org/10.1182/blood-2019-127449

Published: 2019

Journal Articles

Higher Stability of Mutant mRNA As Compared to Wild-Type mRNA in Diffuse Large B-Cell Lymphoma

Blood (2019) 134 (Supplement_1): 1499.

https://doi.org/10.1182/blood-2019-128516

Published: 2019

Journal Articles

Cell of Origin Classification of DLBCL Using Targeted NGS Expression Profiling and Deep Learning

Blood (2019) 134 (Supplement_1): 2891.

https://doi.org/10.1182/blood-2019-126927

Published: 2019

Journal Articles

Higher Stability of Mutant IDH1/2 mRNA As Compared to Wild-Type mRNA in Patients with Acute Myeloid Leukemia

Maher Albitar, MD, Marina Y Konopleva, MD PhD, Ivan De Dios, BS, Jeffrey Justin Estella, BS, MS, Spiraggelos Antzoulatos, Steven M. Kornblau, MD, Antonio Cavazos, Sanam Loghavi, MD, Koichi Takahashi, MD, Hagop M. Kantarjian, MD, Courtney D. DiNardo, MDMSc

Blood (2019) 134 (Supplement_1): 2730.

https://doi.org/10.1182/blood-2019-127383

Published: 2019

Journal Articles

MYC and BCL2 mRNA Expression As Determined By NGS Predicts Survival in DLBCL in GCB but Not in ABC Subgroup

Blood (2019) 134 (Supplement_1): 5092.

https://doi.org/10.1182/blood-2019-128492

Published: 2019

Journal Articles

Sequencing of Circulating Cell-Free DNA in Patients with AML Detects Clinically Significant Mutations Not Detected in Bone Marrow: The Role for Complementary Peripheral Blood and Bone Marrow Genomic Analysis

Nicholas J. Short, MD, Keyur Patel, MD PhD, Maher Albitar, MD, Miguel Franquiz, Rashmi Kanagal-Shamanna, MD, Feng Wang, PhD, Rita Assi, MD, Guillermo Montalban-Bravo, MD, Jairo Matthews, Wanlong Ma, Ghayas C. Issa, MD, Steven M. Kornblau, MD, Elias Jabbour, MD, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, Zeev E. Estrov, MD, Farhad Ravandi, MD

Blood (2019) 134 (Supplement_1): 2592.

https://doi.org/10.1182/blood-2019-125122

Published: 2019

Journal Articles

Immunophenotyping Using Targeted RNA NGS Recapitulates Traditional AML and CLL FLOW Fingerprints

Cynthie Wong, PhD, Vincent Funari, PhD, Maher Albitar, MD

Blood (2018) 132 (Supplement 1): 5256.

https://doi.org/10.1182/blood-2018-99-119085

Published: 2018

Journal Articles

Validation of Clinical Prognostic Models and Integration of Genetic Biomarkers of Drug Resistance in CLL Patients Treated with Ibrutinib

Inhye E. Ahn, MD, Xin Tian, Maher Albitar, MD, Sarah E. M. Herman, PhD, Erika M. Cook, Susan Soto, Wanlong Ma, David Ipe, L. Claire Tsao, Mei Cheng, James P. Dean, Adrian Wiestner, MD

Blood (2018) 132 (Supplement 1): 186.

https://doi.org/10.1182/blood-2018-99-110326

Published: 2018

Journal Articles

RNA Expression Profile Using Targeted NGS As a Potential Predictor of Early Molecular Response and Relapse in Core-Binding Factor Acute Myeloid Leukemia

Mahesh Swaminathan, MD, Nicholas Stavrou, Spiraggelos Antzoulatos, Maher Albitar, MD, Keyur Patel, MD PhD, Jorge E. Cortes, MD, Courtney D. DiNardo, MD MSc, Tapan M. Kadia, MD, Elias J. Jabbour, MD, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, Gautam Borthakur, MD

Blood (2018) 132 (Supplement 1): 5113.

https://doi.org/10.1182/blood-2018-99-119098

Published: 2018

Journal Articles

Molecular Epidemiologic Associations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) within the United States

Adam Zrinski Albitar, BS, Neil Shah, MD, James K McCloskey, MD, Jamie L. Koprivnikar, MD, Jianhua Zhao, PhD, Chirag Desai, MS, MBA, Sucha Sudarsanam, MS, Maher Albitar, MD, Catherine E. Lai, MD

Blood (2018) 132 (Supplement 1): 1393.

https://doi.org/10.1182/blood-2018-99-117365

Published: 2018

Journal Articles

Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome (MDS)

Alana Vicente, MD, Fernanda Gutierrez-Rodrigues, PhD, Valentina Giudice, MD, Zhijie Wu, MD PhD, Sachiko Kajigaya, PhD, Maria del Pilar Fernandez Ibanez, Maher Albitar, MD, Barbara Weinstein, RN, Katherine R. Calvo, MD PhD, Danielle M. Townsley, MDMSc, Phillip Scheinberg, MD, Cynthia E. Dunbar, MD, Neal S. Young, MD, Thomas Winkler, MD

Blood (2018) 132 (Supplement 1): 229.

https://doi.org/10.1182/blood-2018-99-119780

Published: 2018

Journal Articles

Venetoclax in Combination with FLAG-IDA Chemotherapy (FLAG-V-I) for Fit, Relapsed/Refractory AML Patients: Interim Results of a Phase 1b/2 Dose Escalation and Expansion Study

Courtney D. DiNardo, MD MSc, Maher Albitar, MD, Tapan M. Kadia, MD, Kiran Naqvi, MD MPH, Kenneth Vaughan, RN, Antonio Cavazos, MSc, Sherry A. Pierce, BSN, BA, Koichi Takahashi, MD, Steven M. Kornblau, MD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Marina Y. Konopleva, MD PhD

Blood (2018) 132 (Supplement 1): 4048.

https://doi.org/10.1182/blood-2018-99-114812

Published: 2018

Journal Articles

MDS Diagnosis Using cfRNA Profiling By Targeted Enrichment Next Generation Sequencing

Cynthie Wong, PhD, Vincent Funari, PhD, Wanlong Ma, MS, Ivan De Dios, BS, Forrest Blocker, PhD, Babak Shahbaba, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 4268.

https://doi.org/10.1182/blood.V130.Suppl_1.4268.4268

Published: 2017

Journal Articles

Clonal Hematopoiesis in Normal Individuals Is Not Random and Likely Reflects Early MDS

Wanlong Ma, MS, Ivan De Dios, BS, Vincent Funari, PhD, Sucha Sudarsanam, MS, Shi-Ping Jiang, MD, Sally Agersborg, MD PhD, Jennifer Hummel, MD MPH, Forrest Blocker, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 4269.

https://doi.org/10.1182/blood.V130.Suppl_1.4269.4269

Published: 2017

Journal Articles

Liquid Biopsy As a Diagnostic Test for Myelodysplastic Syndrome and Other Acute and Chronic Myeloid Neoplasms

Wanlong Ma, MS, Ivan De Dios, BS, Vincent Funari, PhD, Shi-Ping Jiang, MD, Sally Agersborg, MD PhD, Jennifer Hummel, MD MPH, Forrest Blocker, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 4270.

https://doi.org/10.1182/blood.V130.Suppl_1.4270.4270

Published: 2017

Journal Articles

FLT3 Mutation in Acute Myeloid Leukemia: Primary or Secondary Mutation?

Wanlong Ma, MS, Ivan De Dios, BS, Vincent Funari, PhD, Sucha Sudarsanam, MS, Shi-Ping Jiang, MD, Sally Agersborg, MD PhD, Jennifer Hummel, MD MPH, Forrest Blocker, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 2668.

https://doi.org/10.1182/blood.V130.Suppl_1.2668.2668

Published: 2017

Journal Articles

Using Targeted Enrichment RNA Sequencing in the Diagnosis of Hematologic Neoplasms in Fresh and Paraffin-Embedded Tissue

Wanlong Ma, MS, Ivan De Dios, BS, Vincent Funari, PhD, Babak Shahbaba, PhD, Forrest Blocker, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 5118.

https://doi.org/10.1182/blood.V130.Suppl_1.5118.5118

Published: 2017

Journal Articles

Potential Familial Predisposition to Hematologic Neoplasm Detected Incidentally in Adult Patients Presenting with Myeloid Neoplasms

Vincent Funari, PhD, Maya Thangavelu, PhD, Wanlong Ma, MS, Ivan De Dios, BS, Sally Agersborg, MD PhD, Forrest Blocker, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 585.

https://doi.org/10.1182/blood.V130.Suppl_1.585.585

Published: 2017

Journal Articles

IDH1 and IDH2 : Founding or Progressor Mutations in Myeloid Neoplasms

Wanlong Ma, MS, Ivan De Dios, BS, Vincent Funari, PhD, Sucha Sudarsanam, MS, Shi-Ping Jiang, MD, Sally Agersborg, MD PhD, Jennifer Hummel, MD MPH, Forrest Blocker, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 405.

https://doi.org/10.1182/blood.V130.Suppl_1.405.405

Published: 2017

Journal Articles

Interclonal and Intraclonal Heterogeneity in Patients with IDH1/2 Mutation

Wanlong Ma, BS, Maya Thangavelu, PhD, Ivan De Dios, BS, Vincent Funari, PhD, Maher Albitar, MD

Blood (2016) 128 (22): 1689.

https://doi.org/10.1182/blood.V128.22.1689.1689

Published: 2016

NARROW

Expression Profiling of mRNA By Next Generation Sequencing and the Development of Algorithm for Predicting Response in Acute Myeloid Leukemia

Higher Stability of Mutant mRNA As Compared to Wild-Type mRNA in Diffuse Large B-Cell Lymphoma

Cell of Origin Classification of DLBCL Using Targeted NGS Expression Profiling and Deep Learning

Higher Stability of Mutant IDH1/2 mRNA As Compared to Wild-Type mRNA in Patients with Acute Myeloid Leukemia

MYC and BCL2 mRNA Expression As Determined By NGS Predicts Survival in DLBCL in GCB but Not in ABC Subgroup

Sequencing of Circulating Cell-Free DNA in Patients with AML Detects Clinically Significant Mutations Not Detected in Bone Marrow: The Role for Complementary Peripheral Blood and Bone Marrow Genomic Analysis

Immunophenotyping Using Targeted RNA NGS Recapitulates Traditional AML and CLL FLOW Fingerprints

Validation of Clinical Prognostic Models and Integration of Genetic Biomarkers of Drug Resistance in CLL Patients Treated with Ibrutinib

RNA Expression Profile Using Targeted NGS As a Potential Predictor of Early Molecular Response and Relapse in Core-Binding Factor Acute Myeloid Leukemia

Molecular Epidemiologic Associations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) within the United States

Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome (MDS)

Venetoclax in Combination with FLAG-IDA Chemotherapy (FLAG-V-I) for Fit, Relapsed/Refractory AML Patients: Interim Results of a Phase 1b/2 Dose Escalation and Expansion Study

MDS Diagnosis Using cfRNA Profiling By Targeted Enrichment Next Generation Sequencing

Clonal Hematopoiesis in Normal Individuals Is Not Random and Likely Reflects Early MDS

Liquid Biopsy As a Diagnostic Test for Myelodysplastic Syndrome and Other Acute and Chronic Myeloid Neoplasms

FLT3 Mutation in Acute Myeloid Leukemia: Primary or Secondary Mutation?

Using Targeted Enrichment RNA Sequencing in the Diagnosis of Hematologic Neoplasms in Fresh and Paraffin-Embedded Tissue

Potential Familial Predisposition to Hematologic Neoplasm Detected Incidentally in Adult Patients Presenting with Myeloid Neoplasms

IDH1 and IDH2 : Founding or Progressor Mutations in Myeloid Neoplasms

Interclonal and Intraclonal Heterogeneity in Patients with IDH1/2 Mutation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only